Skip to main content

Advertisement

Log in

Remission of type 2 diabetes after omega loop gastric bypass for morbid obesity

  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background

Roux-en-Y gastric bypass (RYGBP) is a validated technique for the treatment of morbid obesity and results in a significant rate of remission of type 2 diabetes (T2D). Omega gastric bypass (OGBP) is an effective and simpler alternative for weight loss, but its effect on T2D is unclear.

Methods

Between December 2006 and September 2012, 804 laparoscopic OGBPs were carried out in our centre. Among these, 100 (12.4 %) patients had T2D at the time of the intervention. Remission of T2D was defined by a glycated haemoglobin (HbA1c) level of <6 % without concomitant treatment.

Results

Postoperative follow-up was completed by 81 patients (mean age: 49 ± 11 years; mean weight at surgery: 133 ± 29 kg; mean body mass index (BMI): 47 ± 9 kg/m2). Mean preoperative HbA1c was 8 ± 2 g/dL. Before OGBP, seven patients (9 %) had received no oral hypoglycaemic treatment, 30 (37 %) had received monotherapy, 26 (32 %) bitherapy, six (7 %) tritherapy and 12 (15 %) patients had used insulin. Over a mean follow-up of 26 months (range 1–75), mean weight decreased to 94 ± 23 kg and mean BMI to 35 kg/m2. Seventy-one (88 %) patients had complete remission of T2D and the other 10 (12 %) had reduced their treatment. Seven patients (58 %) initially treated with insulin no longer required this treatment. Mean time to remission of T2D for patients receiving one or more oral therapies versus insulin was 6.9 versus 17.9 months.

Conclusions

OMBP is effective treatment for obesity in terms of weight loss and remission of T2D.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Sjostrom CD, Lissner L, Wedel H, Sjostrom L (1999) Reduction in incidence of diabetes, hypertension, and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 7(5):477–484

    Article  CAS  PubMed  Google Scholar 

  2. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122(3):248–256

    Article  PubMed  Google Scholar 

  3. Pories WJ, Mac Donald KG, Morgan EJ Jr, Sinha MK, Dohm GL, Swanson MS et al (1992) Surgical treatment of obesity and its effect on diabetes: 10-year follow-up. Am J Clin Nutr 55(2 Suppl):582S–585S

    CAS  PubMed  Google Scholar 

  4. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E, Rao RH, Kuller L, Kelley D (2003) Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 238(4):467–484

    PubMed Central  PubMed  Google Scholar 

  5. Iaconelli A, Panunzi S, De Gaetano A, Manco M, Guidone C, Leccesi L, Gniuli D, Nanni G, Castagneto M, Ghirlanda G, Mingrone G (2011) Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up. Diabetes Care 34(3):561–567

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Rutledge R (2001) The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg 11(3):276–280

    Article  CAS  PubMed  Google Scholar 

  7. Lee WJ, Yu PJ, Wang W, Chen TC, Wei PL, Huang MT (2005) Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg 242(1):20–28

    Article  PubMed Central  PubMed  Google Scholar 

  8. Kim Z, Hur KY (2011) Laparoscopic mini-gastric bypass for type 2 diabetes: the preliminary report. World J Surg 35(3):631–636

    Article  PubMed  Google Scholar 

  9. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292(14):1724–1737

    Article  CAS  PubMed  Google Scholar 

  10. Arterburn DE, Bogart A, Sherwood NE, Sidney S, Coleman KJ, Haneuse S, O’Connor PJ, Theis MK, Campos GM, McCulloch D, Selby J (2013) A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg 23(1):93–102

    Article  PubMed  Google Scholar 

  11. Abbatini F, Rizzello M, Casella G, Alessandri G, Capoccia D, Leonetti F, Basso N (2010) Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc 24(5):1005–1010

    Article  CAS  PubMed  Google Scholar 

  12. American Diabetes Association, Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, Franz MJ, Hoogwerf BJ, Lichtenstein AH, Mayer-Davis E, Mooradian AD, Wheeler ML (2008) Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 31(Suppl 1):S61–78

  13. American Diabetes Association (2011) Executive summary: standards of medical care in diabetes—2011. Diabetes Care 34(Suppl 1):S4–S10

    Google Scholar 

  14. Carbajo M, García-Caballero M, Toledano M, Osorio D, García-Lanza C, Carmona JA (2005) One-anastomosis gastric bypass by laparoscopy: results in the first 209 patients. Obes Surg 15(3):398–404

    Article  PubMed  Google Scholar 

  15. Chakhtoura G, Zinzindohoué F, Ghanem Y, Ruseykin I, Dutranoy JC, Chevallier JM (2008) Primary results of laparoscopic mini-gastric bypass in a French obesity-surgery specialized university hospital. Obes Surg 18(9):1130–1133

    Article  PubMed  Google Scholar 

  16. Kula KS, Machanda N (2010) Comparison of laparoscopic mini gastric bypass with Roux-en-Y gastric bypass for the treatment of morbid obesity. Surg Obes Relat Dis 6(3):S63–S64

    Article  Google Scholar 

  17. Lee WJ, Lee YC, Ser KH, Su YH, Chen SC (2010) Revisional surgery of laparoscopic mini-gastric bypass: a nine-year follow-up. Surg Obes Relat Dis 6(3):S15

    Article  Google Scholar 

  18. Rutledge R, Walsh TR (2005) Continued excellent results with the mini-gastric bypass: six-year study in 2,410 patients. Obes Surg 15(9):1304–1308

    Article  PubMed  Google Scholar 

  19. Wang W, Wei PL, Lee YC, Huang MT, Chiu CC, Lee WJ (2005) Short-term results of laparoscopic mini-gastric bypass. Obes Surg 15(5):648–654

    Article  PubMed  Google Scholar 

  20. Fobi M1, Lee H, Igwe D, Felahy B, James E, Stanczyk M, Fobi N (2002) Gastric bypass in patients with BMI < 40 but >32 without life-threatening co-morbidities: preliminary report. Obes Surg 12(1):52–56

  21. Huang CK, Shabbir A, Lo CH, Tai CM, Chen YS, Houng JY (2011) Roux-en-Y gastric bypass for the treatment of type II diabetes mellitus in Chinese patients with body mass index of 25–35. Obes Surg 21(9):1344–1349

    Article  PubMed Central  PubMed  Google Scholar 

  22. Hayes MT, Hunt LA, Foo J, Tychinskaya Y, Stubbs RS (2011) A model for predicting the resolution of type 2 diabetes in severely obese subjects following Roux-en Y gastric bypass surgery. Obes Surg 21(7):910–916

    Article  PubMed  Google Scholar 

  23. Campos GM, Rabl C, Mulligan K, Posselt A, Rogers SJ, Westphalen AC, Lin F, Vittinghoff E (2008) Factors associated with weight loss after gastric bypass. Arch Surg 143(9):877–883

    Article  PubMed Central  PubMed  Google Scholar 

  24. Carbonell AM, Wolfe LG, Meador JG, Sugerman HJ, Kellum JM, Maher JW (2008) Does diabetes affect weight loss after gastric bypass? Surg Obes Relat Dis 4(3):441–444

  25. Chikunguwo SM, Wolfe LG, Dodson P, Meador JG, Baugh N, Clore JN, Kellum JM, Maher JW (2010) Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes Relat Dis 6(3):254–259

  26. Cummings DE (2009) Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery. Int J Obes (Lond) 33(Suppl 1):S33–S40

    Article  CAS  Google Scholar 

  27. DiGiorgi M, Rosen DJ, Choi JJ, Milone L, Schrope B, Olivero-Rivera L, Restuccia N, Yuen S, Fisk M, Inabnet WB, Bessler M (2010) Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes Relat Dis 6(3):249–253

    Article  PubMed  Google Scholar 

  28. Hall TC, Pellen MG, Sedman PC, Jain PK (2010) Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg 20(9):1245–1250

    Article  PubMed  Google Scholar 

  29. Melton GB, Steele KE, Schweitzer MA, Lidor AO, Magnuson TH (2008) Suboptimal weight loss after gastric bypass surgery: correlation of demographics, comorbidities, and insurance status with outcomes. J Gastrointest Surg 12(2):250–255

    Article  PubMed  Google Scholar 

  30. Vetter ML, Cardillo S, Rickels MR, Iqbal N (2009) Narrative review: effect of bariatric surgery on type 2 diabetes mellitus. Ann Intern Med 150(2):94–103

    Article  PubMed  Google Scholar 

  31. Sarson DL, Scopinaro N, Bloom SR (1981) Gut hormone changes after jejunoileal (JIB) or biliopancreatic (BPB) bypass surgery for morbid obesity. Int J Obes 5(5):471–480

    CAS  PubMed  Google Scholar 

  32. Sugerman HJ, Wolfe LG, Sica DA, Clore JN (2003) Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 237(6):751–756

    PubMed Central  PubMed  Google Scholar 

  33. Lee WJ, Chong K, Ser KH, Lee YC, Chen SC, Chen JC, Tsai MH, Chuang LM (2011) Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus. A randomized controlled trial. Arch Surg 146(2):143–148

    Article  PubMed  Google Scholar 

  34. Zervos E, Agle SC, Warren AJ, Lang CG, Fitzgerald TL, Dar M, Rotondo MF, Pories WJ (2010) Amelioration of insulin requirement in patients undergoing duodenal bypass for reasons other than obesity implicates foregut factors in the pathophysiology of type II diabetes. J Am Coll Surg 210(5):564–572, 572–574

  35. Nannipieri M, Mari A, Anselmino M, Baldi S, Barsotti E, Guarino D, Camastra S, Bellini R, Berta RD, Ferrannini E (2011) The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery. J Clin Endocrinol Metab 96(9):E1372–E1379

    Article  CAS  PubMed  Google Scholar 

  36. Cummings S, Apovian CM, Khaodhiar L (2008) Obesity surgery: evidence for diabetes prevention/management. J Am Diet Assoc 108(4 Suppl 1):S40–S44

    Article  PubMed  Google Scholar 

  37. Koner J, Inabnet W, Febres G, Conwell IM, McMahon DJ, Salas R, Taveras C, Schrope B, Bessler M (2009) Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes (Lond) 33(7):786–795

    Article  Google Scholar 

  38. Laferrère B, Heshka S, Wang K, Khan Y, McGinty J, Teixeira J, Hart AB, Olivan B (2007) Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 30(7):1709–1716

    Article  PubMed Central  PubMed  Google Scholar 

  39. Mingrone G, Castagneto-Gissey L (2009) Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery. Diabetes Metab 35(6 Pt 2):518–523

    Article  CAS  PubMed  Google Scholar 

  40. Morínigo R, Moizé V, Musri M, Lacy AM, Navarro S, Marín JL, Delgado S, Casamitjana R, Vidal J (2006) GLP-1, PYY, hunger and satiety following gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 91(5):1735–1740

    Article  PubMed  Google Scholar 

  41. Pournaras DJ, Osbrone A, Hawkins S, Vincent RP, Mahon D, Ewings P, Ghatei MA, Bloom SR, Welbourn R, le Roux CW (2010) Remission of type 2 diabetes after gastric bypass and banding: mechanism and 2 year outcomes. Ann Surg 252(6):966–971

    Article  PubMed  Google Scholar 

  42. Lee WJ, Chong K, Chen CY, Chen SC, Lee YC, Ser KH, Chuang LM (2011) Diabetes remission and insulin secretion after gastric bypass in patients with body mass index <35 kg/m2. Obes Surg 21(7):889–895

    Article  PubMed  Google Scholar 

Download references

Disclosures

Drs. Guenzi, Arman, Rau, Cordun, Moszkowicz, Voron and Chevallier have no conflicts of interest or financial ties to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Martino Guenzi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guenzi, M., Arman, G., Rau, C. et al. Remission of type 2 diabetes after omega loop gastric bypass for morbid obesity. Surg Endosc 29, 2669–2674 (2015). https://doi.org/10.1007/s00464-014-3987-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-014-3987-7

Keywords

Navigation